Caption Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-18,900
| Closed | -$1.29M | – | 1886 |
|
|
2022
Q3 | $1.29M | Buy |
+18,900
| New | +$1.04M | 0.02% | 782 |
|
|
2021
Q4 | – | Sell |
-94,846
| Closed | -$2.42M | – | 2070 |
|
|
2021
Q3 | $2.42M | Sell |
94,846
-110,154
| -54% | -$3.24M | 0.03% | 691 |
|
|
2021
Q2 | $7.18M | Buy |
+205,000
| New | +$8M | 0.09% | 274 |
|
|
2021
Q1 | – | Sell |
-81,412
| Closed | -$3.74M | – | 1490 |
|
|
2020
Q4 | $3.52M | Buy |
+81,412
| New | +$4.01M | 0.08% | 303 |
|
|
2020
Q3 | – | Sell |
-11,370
| Closed | -$723K | – | 1350 |
|
|
2020
Q2 | $717K | Buy |
+11,370
| New | +$780K | 0.02% | 616 |
|
|
2020
Q1 | – | Sell |
-18,042
| Closed | -$1.44M | – | 1167 |
|
|
2019
Q4 | $1.44M | Buy |
+18,042
| New | +$1.07M | 0.05% | 430 |
|
|
2019
Q3 | – | Sell |
-71,000
| Closed | -$3.7M | – | 951 |
|
|
2019
Q2 | $3.73M | Buy |
71,000
+50,504
| +246% | +$2.9M | 0.19% | 158 |
|
|
2019
Q1 | $1.08M | Buy |
+20,496
| New | +$1.01M | 0.06% | 341 |
|
|
2018
Q4 | – | Sell |
-26,518
| Closed | -$1.01M | – | 682 |
|
|
2018
Q3 | $1.01M | Sell |
26,518
-5,382
| -17% | -$238K | 0.06% | 340 |
|
|
2018
Q2 | $1.44M | Buy |
+31,900
| New | +$1.45M | 0.11% | 212 |
|
Other funds holding GBT
Caption Management's GBT Position: Q4 2022 in Review
Caption Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 18,900 shares — an estimated $1.29M sold.
Caption Management first reported a position in GBT in Q2 2018 and held it in 10 quarters. The position peaked at $7.18M in Q2 2021. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Caption Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Caption Management sold 18,900 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1.29M.
- Caption Management first reported a position in Global Blood Therapeutics, Inc. in Q2 2018 and held it in 10 quarters.
- Caption Management's Global Blood Therapeutics, Inc. position peaked at $7.18M in Q2 2021.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.